| Tyyppi : |
Lehti |
| Internet-yhteys : |
http://www.ajhp.org/cgi/content/abstract/56/4/333 |
|
| Tutkimus Joukkueet : |
Lawrence - The University of Kansas, Department of Pharmaceutical Chemistry |
| Tekijät : |
Haslam JL, Egodage KL, Chen Y, Rajewski RA, Stella V. |
| Otsikko : |
Stability of rifabutin in two extemporaneously compounded oral liquids |
| Numero : |
Am J Health-Syst Pharm ; 56: 333-336. 1999 |
|
| Todisteiden määrä : |
|
| Fyysinen vakaus : |
|
| Kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| Commentairesvaleur : |
|
Luettelo yhdisteistä
 Rifabutin
|
 |
 |
 |
 |
200 mg
Mycobutin® |
|
25°C |
 |
| 84 |
 |
|
|
|
|
|
200 mg
Mycobutin® |
| OraPlus® / OraSweet® (1:1) |
>>10ml |
|
25°C |
|
| 84 |
|
|
|
|
|
|
200 mg
Mycobutin® |
|
30-40°C |
|
| 56 |
|
|
|
|
|
|
200 mg
Mycobutin® |
| OraPlus® / OraSweet® (1:1) |
>>10ml |
|
30-40°C |
|
| 84 |
|
|
|
|
|
|
200 mg
Mycobutin® |
|
4°C |
|
| 84 |
|
|
|
|
|
|
200 mg
Mycobutin® |
| OraPlus® / OraSweet® (1:1) |
>>10ml |
|
4°C |
|
| 84 |
|
|
|
|
|
